Symbols / LUNG Stock $1.27 -0.78% Pulmonx Corporation

Healthcare • Medical Devices • United States • NMS
LUNG (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Glendon E. French
Exch · Country NMS · United States
Market Cap 53.64M
Enterprise Value 40.25M
Income -54.00M
Sales 90.50M
FCF (ttm) -12.53M
Book/sh 1.30
Cash/sh 1.65
Employees 296
Insider 10d —
IPO Oct 01, 2020
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -1.26
PEG —
P/S 0.59
P/B 0.98
P/C —
EV/EBITDA -0.77
EV/Sales 0.45
Quick Ratio 4.11
Current Ratio 5.07
Debt/Eq 104.15
LT Debt/Eq —
EPS (ttm) -1.33
EPS next Y -1.01
EPS Growth —
Revenue Growth -4.90%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-04-29
Earnings (prior) 2026-03-04
ROA -22.96%
ROE -77.19%
ROIC —
Gross Margin 74.19%
Oper. Margin -43.82%
Profit Margin -59.67%
Shs Outstand 42.24M
Shs Float 37.39M
Insider Own 4.66%
Instit Own 81.82%
Short Float 7.91%
Short Ratio 7.04
Short Interest 2.81M
52W High 5.46
vs 52W High -76.74%
52W Low 1.13
vs 52W Low 12.39%
Beta 0.19
Impl. Vol. 2.98%
Rel Volume 0.54
Avg Volume 493.64K
Volume 264.91K
Target (mean) $5.17
Tgt Median $3.50
Tgt Low $2.50
Tgt High $14.00
# Analysts 6
Recom None
Prev Close $1.28
Price $1.27
Change -0.78%
About

Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is designed for solution that includes information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$5.17
Mean price target
2. Current target
$1.27
Latest analyst target
3. DCF / Fair value
$-5.34
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.27
Low
$2.50
High
$14.00
Mean
$5.17

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-05 main Canaccord Genuity Buy → Buy $5
2026-03-05 main D. Boral Capital Buy → Buy $14
2026-02-20 main D. Boral Capital Buy → Buy $14
2025-11-13 main D. Boral Capital Buy → Buy $14
2025-10-28 main Lake Street Buy → Buy $4
2025-10-28 main D. Boral Capital Buy → Buy $14
2025-09-08 main D. Boral Capital Buy → Buy $16
2025-08-01 main Wells Fargo Equal-Weight → Equal-Weight $3
2025-07-31 main Lake Street Buy → Buy $8
2025-07-31 main Stifel Buy → Buy $5
2025-07-31 down Piper Sandler Overweight → Neutral $3
2025-07-31 main D. Boral Capital Buy → Buy $16
2025-05-22 main Citigroup Neutral → Neutral $4
2025-05-01 main Canaccord Genuity Buy → Buy $15
2025-05-01 reit Piper Sandler Overweight → Overweight $9
2025-05-01 main D. Boral Capital Buy → Buy $17
2025-03-11 main D. Boral Capital Buy → Buy $17
2025-03-10 init D. Boral Capital — → Buy $17
2025-02-20 main Citigroup Neutral → Neutral $8
2024-12-11 main Wells Fargo Equal-Weight → Equal-Weight $8
News
RSS: Latest LUNG news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-02 ROSE GEOFFREY BERAN Officer — 100,000 $0.00 $0
2026-03-02 ROSE GEOFFREY BERAN Officer — 7,732 $1.43 $11,057
2026-03-02 RADHAKRISHNAN SRIKANTH Chief Technology Officer — 175,000 $0.00 $0
2026-03-02 RADHAKRISHNAN SRIKANTH Chief Technology Officer — 10,483 $1.43 $14,991
2026-03-02 FRENCH GLENDON E III Chief Executive Officer — 67,813 $1.43 $96,973
2026-03-02 LEHMAN DAVID AARON General Counsel — 150,000 $0.00 $0
2026-03-02 LEHMAN DAVID AARON General Counsel — 12,237 $1.43 $17,499
2025-12-08 FLORIN DANIEL P Director — 23,321 $1.99 $46,409
2025-12-01 SUNG DERRICK Chief Operating Officer — 1,200,000 $0.00 $0
2025-12-01 ROSE GEOFFREY BERAN Officer — 6,322 $1.57 $9,926
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
90.50
+8.01%
83.79
+22.01%
68.67
+27.98%
53.66
Operating Revenue
90.50
+8.01%
83.79
+22.01%
68.67
+27.98%
53.66
Cost Of Revenue
23.36
+7.21%
21.79
+21.56%
17.92
+29.91%
13.80
Reconciled Cost Of Revenue
23.36
+7.21%
21.79
+21.56%
17.92
+29.91%
13.80
Gross Profit
67.14
+8.29%
62.00
+22.16%
50.75
+27.31%
39.87
Operating Expense
120.80
+0.92%
119.70
+6.23%
112.69
+14.40%
98.50
Research And Development
19.49
+10.93%
17.57
-2.82%
18.08
+17.43%
15.40
Selling General And Administration
101.31
-0.81%
102.14
+7.96%
94.61
+13.84%
83.11
Total Expenses
144.16
+1.88%
141.49
+8.33%
130.61
+16.31%
112.30
Operating Income
-53.66
+7.00%
-57.70
+6.83%
-61.94
-5.62%
-58.64
Total Operating Income As Reported
-53.66
+7.00%
-57.70
+6.83%
-61.94
-5.62%
-58.64
EBITDA
-49.17
+3.39%
-50.89
+8.29%
-55.49
+0.89%
-55.99
Normalized EBITDA
-49.17
+3.39%
-50.89
+8.29%
-55.49
+0.89%
-55.99
Reconciled Depreciation
1.05
-29.40%
1.49
-3.55%
1.55
+2.31%
1.51
EBIT
-50.22
+4.13%
-52.39
+8.16%
-57.04
+0.81%
-57.50
Net Income
-54.00
+4.24%
-56.39
+7.31%
-60.84
-3.26%
-58.92
Pretax Income
-53.38
+4.50%
-55.89
+7.26%
-60.27
-2.91%
-58.57
Net Non Operating Interest Income Expense
-0.50
-132.43%
1.55
-33.48%
2.34
+404.54%
0.46
Interest Expense Non Operating
3.15
-10.04%
3.51
+8.51%
3.23
+203.19%
1.07
Net Interest Income
-0.50
-132.43%
1.55
-33.48%
2.34
+404.54%
0.46
Interest Expense
3.15
-10.04%
3.51
+8.51%
3.23
+203.19%
1.07
Interest Income Non Operating
2.65
-47.62%
5.06
-9.11%
5.57
+264.16%
1.53
Interest Income
2.65
-47.62%
5.06
-9.11%
5.57
+264.16%
1.53
Other Income Expense
0.79
+208.59%
0.26
+138.04%
-0.67
-69.95%
-0.40
Other Non Operating Income Expenses
0.79
+208.59%
0.26
+138.04%
-0.67
-69.95%
-0.40
Tax Provision
0.63
+25.20%
0.50
-12.43%
0.57
+61.76%
0.35
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-54.00
+4.24%
-56.39
+7.31%
-60.84
-3.26%
-58.92
Net Income From Continuing Operation Net Minority Interest
-54.00
+4.24%
-56.39
+7.31%
-60.84
-3.26%
-58.92
Net Income From Continuing And Discontinued Operation
-54.00
+4.24%
-56.39
+7.31%
-60.84
-3.26%
-58.92
Net Income Continuous Operations
-54.00
+4.24%
-56.39
+7.31%
-60.84
-3.26%
-58.92
Normalized Income
-54.00
+4.24%
-56.39
+7.31%
-60.84
-3.26%
-58.92
Net Income Common Stockholders
-54.00
+4.24%
-56.39
+7.31%
-60.84
-3.26%
-58.92
Diluted EPS
-1.33
+7.64%
-1.44
+10.00%
-1.60
-0.63%
-1.59
Basic EPS
-1.33
+7.64%
-1.44
+10.00%
-1.60
-0.63%
-1.59
Basic Average Shares
40.69
+4.03%
39.11
+2.99%
37.97
+2.37%
37.10
Diluted Average Shares
40.69
+4.03%
39.11
+2.99%
37.97
+2.37%
37.10
Diluted NI Availto Com Stockholders
-54.00
+4.24%
-56.39
+7.31%
-60.84
-3.26%
-58.92
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
129.29
-20.61%
162.85
-8.40%
177.78
-8.21%
193.68
Current Assets
101.68
-25.37%
136.25
-9.42%
150.42
-10.97%
168.95
Cash Cash Equivalents And Short Term Investments
69.75
-31.27%
101.48
-13.34%
117.10
-17.03%
141.14
Cash And Cash Equivalents
69.75
-1.63%
70.91
-15.13%
83.55
-17.88%
101.74
Cash Equivalents
1.04
-84.31%
6.62
-73.67%
25.13
+440.76%
4.65
Cash Financial
68.71
+6.88%
64.29
+10.05%
58.42
-39.83%
97.09
Other Short Term Investments
0.00
-100.00%
30.58
-8.87%
33.55
-14.84%
39.40
Receivables
12.66
-8.18%
13.79
+5.92%
13.02
+40.32%
9.28
Accounts Receivable
12.07
-7.99%
13.12
+8.38%
12.11
+39.51%
8.68
Gross Accounts Receivable
12.17
-7.93%
13.22
+9.21%
12.11
+37.92%
8.78
Allowance For Doubtful Accounts Receivable
-0.10
+0.00%
-0.10
0.00
+100.00%
-0.10
Taxes Receivable
0.59
-11.92%
0.67
-26.67%
0.92
+51.99%
0.60
Inventory
15.85
-6.33%
16.91
+1.03%
16.74
+14.96%
14.56
Raw Materials
—
—
—
—
Work In Process
—
—
—
—
Finished Goods
—
—
—
—
Prepaid Assets
2.68
+0.07%
2.67
-5.04%
2.82
-18.40%
3.45
Restricted Cash
0.26
+0.39%
0.26
+8.44%
0.24
+2.60%
0.23
Other Current Assets
0.49
-56.51%
1.13
+124.01%
0.50
+73.79%
0.29
Total Non Current Assets
27.61
+3.78%
26.60
-2.77%
27.36
+10.66%
24.72
Net PPE
20.25
-5.61%
21.45
+188.57%
7.43
-29.20%
10.50
Gross PPE
26.90
-1.02%
27.18
+121.14%
12.29
-12.57%
14.06
Accumulated Depreciation
-6.65
-16.18%
-5.72
-17.90%
-4.86
-36.53%
-3.56
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
6.48
+6.16%
6.11
+38.57%
4.41
+6.24%
4.15
Construction In Progress
0.05
-75.24%
0.21
-90.63%
2.20
+20.49%
1.82
Other Properties
18.03
-2.79%
18.55
+444.48%
3.41
-41.34%
5.81
Leases
2.34
+0.78%
2.32
+1.80%
2.28
+0.00%
2.28
Goodwill And Other Intangible Assets
2.33
+0.00%
2.33
-1.31%
2.36
-4.95%
2.49
Goodwill
2.33
+0.00%
2.33
+0.00%
2.33
+0.00%
2.33
Other Intangible Assets
—
—
0.03
-79.87%
0.15
Investments And Advances
—
0.00
-100.00%
14.39
+142.91%
5.92
Other Non Current Assets
5.03
+78.42%
2.82
-11.16%
3.17
-45.44%
5.81
Total Liabilities Net Minority Interest
75.17
-2.42%
77.04
+29.55%
59.47
+49.91%
39.67
Current Liabilities
20.06
-17.92%
24.44
+5.53%
23.16
+25.23%
18.49
Payables And Accrued Expenses
15.18
+12.79%
13.45
+35.23%
9.95
-1.30%
10.08
Payables
5.18
+10.12%
4.70
+99.87%
2.35
-2.12%
2.40
Accounts Payable
3.90
+2.04%
3.83
+155.64%
1.50
-14.85%
1.76
Current Accrued Expenses
10.00
+14.23%
8.75
+15.21%
7.60
-1.04%
7.68
Pensionand Other Post Retirement Benefit Plans Current
3.55
-48.52%
6.89
-12.46%
7.88
+58.36%
4.97
Total Tax Payable
1.27
+45.43%
0.88
+2.34%
0.86
+32.51%
0.65
Income Tax Payable
0.26
+436.73%
0.05
-47.31%
0.09
+389.47%
0.02
Current Debt And Capital Lease Obligation
1.32
-66.72%
3.95
-24.38%
5.23
+57.55%
3.32
Current Debt
0.11
-96.66%
3.18
+47.38%
2.15
+2294.44%
0.09
Other Current Borrowings
0.11
-96.66%
3.18
+47.38%
2.15
+2294.44%
0.09
Current Capital Lease Obligation
1.21
+55.53%
0.78
-74.69%
3.07
-4.80%
3.23
Current Deferred Liabilities
0.02
-86.67%
0.14
+29.81%
0.10
-13.33%
0.12
Current Deferred Revenue
0.02
-86.67%
0.14
+29.81%
0.10
-13.33%
0.12
Total Non Current Liabilities Net Minority Interest
55.12
+4.78%
52.60
+44.88%
36.31
+71.45%
21.18
Long Term Debt And Capital Lease Obligation
55.05
+4.82%
52.52
+45.09%
36.20
+71.68%
21.08
Long Term Debt
36.99
+8.78%
34.00
-3.10%
35.09
+103.60%
17.23
Long Term Capital Lease Obligation
18.06
-2.46%
18.52
+1574.05%
1.11
-71.27%
3.85
Non Current Deferred Liabilities
0.07
-20.69%
0.09
-23.68%
0.11
+21.28%
0.09
Non Current Deferred Taxes Liabilities
0.07
-20.69%
0.09
-23.68%
0.11
+21.28%
0.09
Other Non Current Liabilities
—
—
—
—
Stockholders Equity
54.12
-36.93%
85.81
-27.47%
118.31
-23.18%
154.01
Common Stock Equity
54.12
-36.93%
85.81
-27.47%
118.31
-23.18%
154.01
Capital Stock
0.04
+5.00%
0.04
+2.56%
0.04
+2.63%
0.04
Common Stock
0.04
+5.00%
0.04
+2.56%
0.04
+2.63%
0.04
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
41.67
+4.74%
39.79
+3.30%
38.52
+2.56%
37.56
Ordinary Shares Number
41.67
+4.74%
39.79
+3.30%
38.52
+2.56%
37.56
Additional Paid In Capital
573.27
+4.00%
551.21
+4.63%
526.80
+4.79%
502.71
Retained Earnings
-521.56
-11.55%
-467.56
-13.72%
-411.16
-17.37%
-350.32
Gains Losses Not Affecting Retained Earnings
2.36
+11.69%
2.11
-19.96%
2.64
+67.62%
1.57
Other Equity Adjustments
2.36
+11.69%
2.11
-19.96%
2.64
+67.62%
1.57
Total Equity Gross Minority Interest
54.12
-36.93%
85.81
-27.47%
118.31
-23.18%
154.01
Total Capitalization
91.11
-23.96%
119.81
-21.90%
153.40
-10.42%
171.24
Working Capital
81.63
-27.00%
111.81
-12.14%
127.27
-15.42%
150.46
Invested Capital
91.21
-25.84%
122.99
-20.94%
155.56
-9.21%
171.33
Total Debt
56.36
-0.19%
56.47
+36.32%
41.42
+69.76%
24.40
Capital Lease Obligations
19.27
-0.12%
19.29
+361.56%
4.18
-40.94%
7.08
Net Tangible Assets
51.78
-37.97%
83.48
-28.01%
115.95
-23.47%
151.52
Tangible Book Value
51.78
-37.97%
83.48
-28.01%
115.95
-23.47%
151.52
Available For Sale Securities
—
—
14.39
+142.91%
5.92
Investmentin Financial Assets
—
0.00
-100.00%
14.39
+142.91%
5.92
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-32.38
-2.66%
-31.54
+16.15%
-37.61
+16.58%
-45.08
Cash Flow From Continuing Operating Activities
-32.38
-2.66%
-31.54
+16.15%
-37.61
+16.58%
-45.08
Net Income From Continuing Operations
-54.00
+4.24%
-56.39
+7.31%
-60.84
-3.26%
-58.92
Depreciation Amortization Depletion
1.05
-29.40%
1.49
-3.55%
1.55
+2.31%
1.51
Depreciation And Amortization
1.05
-29.40%
1.49
-3.55%
1.55
+2.31%
1.51
Other Non Cash Items
1.50
-20.83%
1.90
-30.65%
2.73
+7.05%
2.55
Stock Based Compensation
21.23
-7.50%
22.95
+3.86%
22.10
+34.39%
16.45
Provisionand Write Offof Assets
0.00
-100.00%
0.04
+167.80%
-0.06
-209.26%
0.05
Asset Impairment Charge
0.14
-92.02%
1.79
+253.45%
0.51
+4.54%
0.48
Operating Gains Losses
—
—
-0.01
-314.29%
0.01
Gain Loss On Sale Of PPE
—
0.00
+100.00%
-0.01
-314.29%
0.01
Change In Working Capital
-1.93
-13.04%
-1.70
+33.42%
-2.56
+63.53%
-7.01
Change In Receivables
1.07
+182.19%
-1.31
+57.86%
-3.10
-41.74%
-2.19
Changes In Account Receivables
1.07
+182.19%
-1.31
+57.86%
-3.10
-41.74%
-2.19
Change In Inventory
-0.77
-234.06%
-0.23
-124.95%
0.92
+125.23%
-3.64
Change In Prepaid Assets
0.81
+286.47%
-0.44
-664.91%
-0.06
-107.31%
0.78
Change In Payables And Accrued Expense
-1.81
-167.17%
2.70
-6.80%
2.90
+965.81%
0.27
Change In Accrued Expense
-2.28
-593.29%
0.46
-85.45%
3.18
+2031.54%
0.15
Change In Payable
0.46
-79.29%
2.24
+908.66%
-0.28
-325.20%
0.12
Change In Account Payable
0.27
-88.15%
2.28
+760.29%
-0.34
-239.68%
0.25
Change In Other Working Capital
-0.14
-750.00%
-0.02
-500.00%
0.00
-50.00%
0.01
Change In Other Current Assets
-0.14
+73.99%
-0.55
-1416.67%
-0.04
+26.53%
-0.05
Change In Other Current Liabilities
-0.95
+48.93%
-1.87
+41.23%
-3.18
-44.83%
-2.20
Investing Cash Flow
30.48
+74.42%
17.48
+970.75%
-2.01
+52.50%
-4.22
Cash Flow From Continuing Investing Activities
30.48
+74.42%
17.48
+970.75%
-2.01
+52.50%
-4.22
Net PPE Purchase And Sale
-0.45
+68.76%
-1.45
-79.31%
-0.81
+38.77%
-1.32
Purchase Of PPE
-0.45
+68.76%
-1.45
-79.31%
-0.81
+38.77%
-1.32
Capital Expenditure
-0.45
+68.76%
-1.45
-79.31%
-0.81
+38.77%
-1.32
Net Investment Purchase And Sale
30.93
+63.47%
18.92
+1676.92%
-1.20
+58.72%
-2.91
Purchase Of Investment
-5.65
+79.76%
-27.91
+39.58%
-46.20
+2.09%
-47.19
Sale Of Investment
36.59
-21.89%
46.84
+4.08%
45.00
+1.63%
44.28
Financing Cash Flow
0.83
-38.88%
1.36
-93.63%
21.40
+784.66%
2.42
Cash Flow From Continuing Financing Activities
0.83
-38.88%
1.36
-93.63%
21.40
+784.66%
2.42
Net Issuance Payments Of Debt
-0.10
-5.26%
-0.10
-100.48%
19.91
+22980.46%
-0.09
Issuance Of Debt
—
0.00
-100.00%
20.00
0.00
Repayment Of Debt
-0.10
-5.26%
-0.10
-1.06%
-0.09
-8.05%
-0.09
Long Term Debt Issuance
—
0.00
-100.00%
20.00
0.00
Long Term Debt Payments
-0.10
-5.26%
-0.10
-1.06%
-0.09
-8.05%
-0.09
Net Long Term Debt Issuance
-0.10
-5.26%
-0.10
-100.48%
19.91
+22980.46%
-0.09
Net Common Stock Issuance
—
—
—
—
Proceeds From Stock Option Exercised
1.00
-31.21%
1.46
-2.41%
1.49
-41.62%
2.56
Net Other Financing Charges
-0.07
—
—
-0.05
Changes In Cash
-1.06
+91.64%
-12.70
+30.30%
-18.22
+61.15%
-46.89
Effect Of Exchange Rate Changes
-0.09
-221.05%
0.08
+123.53%
0.03
-76.55%
0.14
Beginning Cash Position
71.16
-15.06%
83.78
-17.83%
101.97
-31.43%
148.71
End Cash Position
70.01
-1.62%
71.16
-15.06%
83.78
-17.83%
101.97
Free Cash Flow
-32.83
+0.47%
-32.98
+14.14%
-38.42
+17.21%
-46.40
Interest Paid Supplemental Data
3.11
-10.60%
3.48
+16.69%
2.98
+252.30%
0.85
Income Tax Paid Supplemental Data
0.47
-15.83%
0.56
+18.05%
0.47
+18.34%
0.40
Amortization Of Securities
-0.38
+76.55%
-1.62
-57.66%
-1.02
-402.45%
-0.20
Change In Income Tax Payable
0.19
+610.53%
-0.04
-155.88%
0.07
+154.84%
-0.12
Change In Tax Payable
0.19
+610.53%
-0.04
-155.88%
0.07
+154.84%
-0.12
Common Stock Issuance
—
—
—
—
Issuance Of Capital Stock
—
—
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category